Autonomic instability, as measured by pupillary unrest, is not associated with multiple sclerosis fatigue severity

Multiple Sclerosis

Volumn 8, Issue 3, 2002, Pages 256-260

  Egg, R ^a   Hogl B ^a   Glatzl, S ^a   Beer, R ^a   Berger, Thomas ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Autonomic nervous system; Fatigue impact scale; Fatigue severity scale; Fatigue waves; MS fatigue; Multiple sclerosis; Pupillography

Indexed keywords

AZATHIOPRINE; BETA INTERFERON; GLATIRAMER;

ADOLESCENT; ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM FUNCTION; CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PUPIL REFLEX; PUPILLOGRAPHY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SLEEP PARAMETERS; STATISTICAL ANALYSIS; VAGUS NERVE; AUTONOMIC NEUROPATHY; FATIGUE; HOSPITALIZATION; MIDDLE AGED; PUPIL DISEASE;

ADOLESCENT; ADULT; AUTONOMIC NERVOUS SYSTEM DISEASES; FATIGUE; FEMALE; HUMAN; MALE; MIDDLE AGE; MULTIPLE SCLEROSIS; PUPIL DISORDERS; SEVERITY OF ILLNESS INDEX; HUMANS; MIDDLE AGED;

EID: 0035989156     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458502ms793oa     Document Type: Article

References (34)

1. Symptomatic fatigue in MS
2. The impact of fatigue on patients with MS
3. Fatigue in multiple sclerosis
4. Fatigue and multiple sclerosis: Evidence-based management strategies for fatigue in multiple sclerosis
5. Fatigue in patients with multiple sclerosis: Motor pathway conduction and event-related potentials
6. 18F-fluoro-deoxyglucose positron emission tomography study
7. An electrophysiological study of the mechanisms of fatigue in multiple sclerosis
8. Increased energy cost of walking in multiple sclerosis: Effect of spasticity, ataxia, and weakness
9. Neuromuscular responses of patients with multiple sclerosis
10. Serum interleukin 2 and soluble interleukin 2 receptor in patients with multiple sclerosis who are experiencing severe fatigue
11. Sleep disturbance, fatigue and depression in multiple sclerosis
12. Sleep disturbance, depression, and lesion site in patients with multiple sclerosis
13. Cardiovascular autonomic dysfunction in multiple sclerosis: Correlation with orthostatic intolerance
14. Longitudinal follow-up of cardiovascular reflex tests in multiple sclerosis
15. Subclinical autonomic disturbances in multiple sclerosis
16. Tests of autonomic dysfunction in patients with multiple sclerosis
17. Chronic fatigue syndrome: A hypothesis focusing on the autonomic nervous system
18. Does the chronic fatigue syndrome involve the autonomic nervous system?
19. Is neurally mediated hypotension an unrecognised cause of chronic fatigue?
20. Evaluation of autonomic nervous function by pupil dynamics recording
21. Quantification of sleepiness: A new approach
22. Pupillography as an objective attention test
23. The measurement of fatigue: A new scale
24. Measuring the functional impact of fatigue: Initial validation of the fatigue impact scale
25. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
26. Das Beck-Depressionsinventar (BDI) in der Klinik
27. Mathematical procedures in data recording and processing of pupillary fatigue waves
28. Daytime variations in central nervous system activation measured by a pupillographic sleepiness test
29. Sympathovagal balance. A critical appraisal
30. Sympathovagal balance: How should we measure it?
31. Central autonomic disorders
32. Pupillary function in multiple sclerosis